Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Other financing activities (2017 - 2021)

Regenxbio (RGNX) has 4 years of Other financing activities data on record, last reported at $128000.0 in Q2 2021.

  • For Q2 2021, Other financing activities changed N/A year-over-year to $128000.0; the TTM value through Dec 2021 reached $379000.0, changed N/A, while the annual FY2021 figure was $379000.0, N/A changed from the prior year.
  • Other financing activities reached $128000.0 in Q2 2021 per RGNX's latest filing, down from $251000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $251000.0 in Q1 2021 and bottomed at $84000.0 in Q1 2017.
  • Average Other financing activities over 3 years is $163500.0, with a median of $146000.0 recorded in 2017.